San Diego, CA, United States of America

Mike Allan Royal

This inventor holds 4 USPTO granted patents and 1 published patent application, plus 1 CIPO patent. Top assignees: Mallinckrodt, Inc., Mallinckrodt Hospital Products IP Limited. Active years: 2016-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mike Allan Royal. Retrieved from https://idiyas.com/inventor/mike-allan-royal

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4 

% Patents Active = 100.0


Average Co-Inventor Count = 2.0

ph-index = 2

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2016-2019

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovations of Mike Allan Royal

Introduction

Mike Allan Royal is a notable inventor based in San Diego, CA. He has made significant contributions to the field of medicine, particularly in pain management and fever treatment. With a total of 4 patents to his name, Royal's work has had a meaningful impact on healthcare practices.

Latest Patents

One of his latest patents is focused on reduced dose intravenous acetaminophen. This patent describes compositions and methods for the intravenous administration of acetaminophen at a single dose level of less than about 1000 mg. This innovation is aimed at the treatment or prevention of pain, such as postoperative pain, and/or fever. The emphasis on reduced dosage highlights the importance of effective pain management while minimizing potential side effects.

Career Highlights

Throughout his career, Mike Allan Royal has worked with reputable companies in the pharmaceutical industry. Notably, he has been associated with Mallinckrodt, Inc. and Mallinckrodt Hospital Products IP Limited. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in medical treatments.

Collaborations

Royal has collaborated with various professionals in his field, including his coworker James Bradley Breitmeyer. These collaborations have likely fostered an environment of creativity and innovation, leading to the development of impactful medical solutions.

Conclusion

Mike Allan Royal's contributions to the field of medicine through his patents and collaborations demonstrate his commitment to improving patient care. His work in reduced dose intravenous acetaminophen is a testament to his innovative spirit and dedication to advancing healthcare practices.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…